- Home
- LEGN vs BETA Comparison
LEGN vs BETA Comparison
Compare LEGN & BETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- BETA
- Stock Information
- Founded
- LEGN 2014
- BETA 2017
- Country
- LEGN United States
- BETA United States
- Employees
- LEGN N/A
- BETA N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- BETA Aerospace
- Sector
- LEGN Health Care
- BETA Industrials
- Exchange
- LEGN Nasdaq
- BETA Nasdaq
- Market Cap
- LEGN 5.9B
- BETA 7.0B
- IPO Year
- LEGN 2020
- BETA 2025
- Fundamental
- Price
- LEGN $29.60
- BETA $25.80
- Analyst Decision
- LEGN Strong Buy
- BETA
- Analyst Count
- LEGN 13
- BETA 0
- Target Price
- LEGN $72.92
- BETA N/A
- AVG Volume (30 Days)
- LEGN 1.3M
- BETA 3.3M
- Earning Date
- LEGN 11-12-2025
- BETA 11-28-2025
- Dividend Yield
- LEGN N/A
- BETA N/A
- EPS Growth
- LEGN N/A
- BETA N/A
- EPS
- LEGN N/A
- BETA N/A
- Revenue
- LEGN $909,045,000.00
- BETA $23,068,000.00
- Revenue This Year
- LEGN $68.68
- BETA N/A
- Revenue Next Year
- LEGN $48.49
- BETA N/A
- P/E Ratio
- LEGN N/A
- BETA N/A
- Revenue Growth
- LEGN 74.75
- BETA N/A
- 52 Week Low
- LEGN $27.34
- BETA $23.79
- 52 Week High
- LEGN $45.30
- BETA $39.50
- Technical
- Relative Strength Index (RSI)
- LEGN 30.03
- BETA N/A
- Support Level
- LEGN $29.92
- BETA N/A
- Resistance Level
- LEGN $33.50
- BETA N/A
- Average True Range (ATR)
- LEGN 1.31
- BETA 0.00
- MACD
- LEGN -0.21
- BETA 0.00
- Stochastic Oscillator
- LEGN 7.78
- BETA 0.00
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.